Why Cell Washing Is The Hidden Bottleneck In Gene-Edited Cell Therapy

The ultimate goal of gene-edited cell therapy development is patient impact, which requires scalable and cost-effective manufacturing. Hidden procedural bottlenecks, however, can significantly inflate costs and limit production capacity. Cell washing, integral to traditional electroporation, is one such bottleneck. Each washing cycle demands operator time, specialized equipment, sterile consumables, and risks losing irreplaceable patient-derived cells – all contributing to higher costs of goods (COGs) and longer turnaround times per batch. This inefficiency ultimately impacts how many patients can access these treatments.

FEMTOBIOMED addresses this specific economic and logistical hurdle with CellShot® PFEP™, a wash-free gene delivery system designed for efficiency and scalability. Explore how eliminating washing steps can improve manufacturing economics. Access the full article to learn more.